-
Featured
New Targeted Glioma Therapy Could Suppress Tumor Growth
Mass General has developed a genotype-targeted therapy for glioma, designed to be given at the tumor site during surgery, and an accompanying rapid diagnostic.
-
Featured
Surviving Gliomas Through Antibodies and Vaccination
Immunotherapy for glioma is under active investigation, but tumor-associated immunosuppression is a major obstacle. A Mass General team studied an investigational monoclonal antibody in mice with glioma, alone and in combination with tumor cell vaccination.
-
Featured
How Liquid Biopsy Could Improve Brain Tumor Treatment and Diagnoses
Mass General doctors are developing a liquid biopsy for brain tumors to reduce the need for invasive tissue biopsies.
-
Treating Brain Tumors with Car T-Cells
In this video, Bob Carter, MD, PhD, chief of Neurosurgery Service, discusses an active research program at Massachusetts General Hospital that's involved in developing Car T cell therapy for brain tumors.
-
Surgery May Not Improve Survival After First Documented Progression of Glioblastoma
After controlling for several potentially confounding factors, neurosurgeons at Massachusetts General Hospital found that resection of progressive glioblastoma is not significantly associated with prolonged post-progression survival, even if gross total resection is achieved.
-
New Subtype of Glioblastoma Identified
Massachusetts General Hospital neurooncologists have identified a subgroup of IDH wild-type glioblastomas that have a distinct clinical and molecular profile. The findings may have significant implications for targeted therapy in these patients.
Brain Tumor contributors
-
Bob S. Carter, MD, PhD
Chief, Neurosurgery Service
Recent Article
Treating Brain Tumors with Car T-Cells
-
Brian V. Nahed, MD, MSc
Neurosurgical Oncology / Brain Tumor Surgeon / Mass General Brain Tumor Center, Neurosurgical Spinal Disorders, Associate Professor, Harvard Medical School
Associate Director Mass General Neurosurgery ProgramRecent Article
How Liquid Biopsies Can Improve Brain Tumor Diagnoses
-
-
William T. Curry, MD
Co-Director, Mass General Neuroscience , Director of Neurosurgical Oncology
Recent Article
Surgery May Not Improve Survival After First Documented Progression of Glioblastoma
Neuroscience Care at Mass General
Through a combination of unmatched expertise, creativity and compassion, Mass General Neuroscience relentlessly advances the fields of Neurosurgery, Neurology and Psychiatry to unleash our patients’ potential.Resource Links
